Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 84,355 shares at $20.14 ($1.7M) on 2026-06-17, disclosed to the SEC on 2026-06-22.
Scheduled sale ($1.7M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.14 | 37,454 | $754K | 44.5% |
| 2 | $20.07 | 46,901 | $941K | 55.5% |
| Total | $20.10 avg | 84,355 | $1.7M | 100% |
| Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |
| DYN | SELL | 2026-04-17 | $2.0M | — | Filing → |